Clinical Trials List
2023-03-20 - 2030-06-30
Phase III
Recruiting6
ICD-10C67.8
Malignant neoplasm of overlapping sites of bladder
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9188.8
Malignant neoplasm of other specified sites of bladder
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳冠亨 Division of Urology
- Han Chang Division of Others -
- Po-Jen Hsiao Division of Urology
- Yi-Huei Chang Division of Urology
- Wei-Ching Lin Division of Radiology
- 蔡禮賢 Division of Urology
- Po-Fan Hsieh Division of Urology
- Chi-Ping Huang Division of Urology
- 賴俊佑 Division of Urology
- Chao-Hsiang Chang Division of Urology
- Yu-De Wang Division of Urology
- Chi-Rei Yang Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jian-Ri Li Division of Urology
- JU-CHUAN HU Division of Urology
- Chuan-Shu Chen Division of Urology
- 盧嘉文 Division of Urology
- 王樹吉 Division of Urology
- 洪晟鈞 Division of Urology
- Cheng-Che Chen Division of Urology
- 廖博崎 Division of Urology
- 張文 Division of Urology
- 林雁婷 Division of Radiology
- 張瓈文 Division of Urology
- Cheng-Kuang Yang Division of Urology
- 賴谷順 Division of Urology
- Chia-Yen Lin Division of Urology
- 梅承恩 Division of Urology
- 裘坤元 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-Ping Lin Division of Urology
- Yen-Hwa Chang Division of Urology
- William Huang Division of Urology
- Ming-Hsuan Ku Division of Urology
- Yu-Hua Fan Division of Urology
- Tzu-Hao Huang Division of Urology
- Tzu-chun Wei Division of Urology
- Chih-Chieh Lin Division of Urology
- Tzu-Hsiang Hsu Division of Urology
- I-Shen Huang Division of Urology
- Jia-An Hong Division of Radiology
- 陳威任 Division of Urology
- Hsiao-Jen Chung Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching-Chia Li Division of Urology
- Tsu-Ming Chien Division of Urology
- 黃琮懿 Division of Urology
- 阮雍順 Division of Urology
- 張顥瀚 Division of Urology
- 柯宏龍 Division of Urology
- 柯宏龍  Division of Urology
- Hsiang Ying Lee Division of Urology
- Sheng-Chen Wen Division of Urology
- 張顥瀚 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王翔生 Division of Others
- 黃亮鋼 Division of Urology
- Po-Jung Su Division of Hematology & Oncology
- Hong-Cheng Gan Division of Urology
- Kai-Jie Yu Division of Urology
- Yung-Chang Lin Division of Hematology & Oncology
- Yuan-Cheng Chu Division of Urology
- PO-HUNG LIN Division of Urology
- Ming-Li Hsieh Division of Urology
- 吳俊德 Division of Urology
- Rita cheng Division of Urology
- I-hung Shao Division of Urology
- 黃文冠 Division of Hematology & Oncology
- 張鈞弼 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
1050 participants
